DBV TECHNOLOGIES S.A. 3,552,500 Ordinary Shares and 3,329,784 American Depositary Shares, each representing one half of one Ordinary Share UNDERWRITING AGREEMENTUnderwriting Agreement • April 4th, 2019 • DBV Technologies S.A. • Biological products, (no disgnostic substances) • New York
DBV Technologies S.A., a société anonyme incorporated under the laws of France, registered with the registre du commerce et des sociétés of Nanterre under number 441 772 522, the registered office of which is 177-181, avenue Pierre Brossolette, 92120 Montrouge, France (the “Company”), proposes to issue and sell, in a capital increase reserved to specified categories of investors with a view to distribution in accordance with the terms hereof to the several underwriters named in Schedule II-1 (the “U.S. Underwriters”) and Schedule II-2 (the “European Underwriters”) hereto (together, the “Underwriters”), for whom you are acting as managers (the “Managers”), (i) 3,552,500 ordinary shares, €0.10 nominal value per share (the “Ordinary Shares”) of the Company (the “European Firm Shares”), and (ii) 1,664,892 Ordinary Shares (the “U.S. Firm Shares”), which Ordinary Shares may be in the form of American Depositary Shares (“ADSs”). In addition, at the option of the Underwriters, the Company has
